Hansa Biopharma announces participation in Fall investor conferences and provides updated financial calendar
Hansa Biopharma to participate in several leading global healthcare conferences in SeptemberLund, Sweden August 31, 2021 Hansa Biopharma AB “Hansa”, (Nasdaq Stockholm: HNSA), the pioneer in enzyme technology for rare immunological conditions, today announced that the Company’s management team will present at the following upcoming investor conferences during September 2021: · Erik Penser Access Minibolags dag, Malmö Tuesday August 31, 2021 at 17:15 (CET) · Pareto Securities Health Care Conference on Thursday September 2 2021, at 13:10 (CET) · Redburn Gene Therapy Virtual Summit